Citadel Advisors
NMRA icon

Citadel Advisors’s Neumora Therapeutics NMRA Stock Holding History

Citadel Advisors’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$670K Sell
343,586
-162,217
-32% -$420K ﹤0.01% 8591
2025
Q4 		$905K Buy
+505,803
New +$1.11M ﹤0.01% 7616
2025
Q3 		– Sell
-17,187
Closed -$27.8K – 13820
2025
Q2 		$12.6K Buy
+17,187
New +$13K ﹤0.01% 12179
2025
Q1 		– Sell
-144,769
Closed -$248K – 15349
2024
Q4 		$1.53M Buy
144,769
+144,699
+206,713% +$1.73M ﹤0.01% 6182
2024
Q3 		$925 Sell
70
-860,373
-100% -$10M ﹤0.01% 13933
2024
Q2 		$8.46M Sell
860,443
-963,540
-53% -$9.97M 0.01% 2995
2024
Q1 		$25.1M Sell
1,823,983
-19,308
-1% -$312K 0.02% 1846
2023
Q4 		$30.3M Sell
1,843,291
-325,227
-15% -$3.99M 0.03% 1609
2023
Q3 		$29.7M Buy
+2,168,518
New +$27.1M 0.03% 1509

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return